How Does Nasonex Work in the Body

Chemical Composition, Mechanism of Action & Metabolic Effects Explained

Key Takeaways: How Nasonex Works

  • Active Ingredient: Mometasone furoate (50 micrograms/actuation), a potent synthetic corticosteroid.
  • Primary Action: Reduces inflammation in the nasal passages by suppressing pro‑inflammatory cytokines and immune cell infiltration.
  • Onset & Duration: Some relief within 12 hours; full benefit after 2‑4 days. Once‑daily dosing provides 24‑hour control.
  • Metabolism: Minimal systemic absorption (<0.1%); absorbed fraction is extensively metabolised in the liver (CYP3A4) and excreted via faeces.
  • Indications: Allergic rhinitis (seasonal and perennial) in adults and children ≥3 years; nasal polyps in adults ≥18 years.

Nasonex contains mometasone furoate, a locally‑acting corticosteroid that targets inflammation at the nasal mucosa. By reducing swelling and irritation, it relieves sneezing, itching, and nasal congestion without significant systemic side effects.

Important Medical Advice

Stop using Nasonex and seek immediate medical help if you experience facial/tongue/throat swelling, difficulty swallowing, hives, wheezing, or trouble breathing — these may be signs of a severe allergic reaction. Do not use Nasonex if you have an untreated nasal infection (e.g., herpes) or recent nasal surgery until healed.

Chemical Composition of Nasonex

Nasonex Nasal Spray contains the active substance mometasone furoate (as monohydrate) 50 micrograms per actuation. It belongs to the glucocorticoid class of corticosteroids, characterised by a furoate ester at the 17α position which enhances receptor affinity and lipophilicity.

Structural Details

Mometasone furoate

(11β,16α)-9,21-dichloro-11-hydroxy-16-methylpregna-1,4-diene-3,20-dione 17-(2-furoate)

Synthetic corticosteroid with high affinity for the glucocorticoid receptor. The furoate moiety increases lipophilicity, promoting retention in nasal tissues.

Excipients (per spray)

Dispersible cellulose, glycerol, sodium citrate, citric acid monohydrate, polysorbate 80, benzalkonium chloride (0.02 mg), purified water

Benzalkonium chloride acts as a preservative; patients with sensitive nasal mucosa should be monitored for irritation with long‑term use.

Key Pharmaceutical Properties

PropertyValue
Lipophilicity (logP)~4.1
Protein binding98‑99%
Systemic bioavailability (intranasal)<0.1%
Receptor affinityHigh (glucocorticoid receptor)

🗒️ Pharmaceutical insight: The aqueous suspension formulation ensures uniform dose delivery; shaking before use redisperses the micronised mometasone particles.

Mechanism of Action: How Nasonex Works

Mometasone furoate exerts its anti‑inflammatory effects through genomic and non‑genomic pathways, primarily within the nasal mucosa.

  1. Glucocorticoid receptor binding: After diffusion into target cells, mometasone binds to cytoplasmic glucocorticoid receptors. The ligand‑receptor complex translocates to the nucleus.
  2. Gene transcription modulation: It suppresses pro‑inflammatory genes (encoding cytokines like IL‑4, IL‑5, IL‑13, and chemokines) and activates anti‑inflammatory genes (e.g., lipocortin‑1, IκBα).
  3. Cellular effects: Reduction in eosinophil, mast cell, and macrophage recruitment; decreased mediator release; stabilisation of vascular endothelium.
ParameterClinical Timeline
Onset of symptom relief12 hours after first dose
Peak anti‑inflammatory effect2‑4 days
Duration of action24 hours (once‑daily dosing)

🗒️ Physiological insight: Unlike oral corticosteroids, Nasonex delivers high local concentrations directly to inflamed nasal tissue, minimising systemic exposure.

Absorption & Distribution (Pharmacokinetics)

Following intranasal administration of recommended doses, plasma concentrations of mometasone furoate are typically below the lower limit of quantitation, reflecting minimal systemic absorption (<0.1% of the dose).

Pulmonary / Nasal absorption

Any fraction absorbed from the nasal cavity undergoes rapid first‑pass metabolism in the liver, further reducing systemic availability.

Distribution

Mometasone furoate is highly lipophilic, leading to extensive tissue distribution and high protein binding (98‑99%). Volume of distribution is large (approximately 332 L after IV administration).

Metabolic Effects & Elimination

Metabolism: The absorbed fraction is extensively metabolised in the liver, primarily by the cytochrome P450 3A4 (CYP3A4) isoenzyme, to multiple metabolites. The major metabolites are 6β‑hydroxy‑mometasone furoate and 21‑hydroxy‑mometasone furoate, which have negligible glucocorticoid activity.

Excretion: Metabolites are eliminated mainly in the faeces (approximately 74%) via biliary excretion, and to a lesser extent in urine (about 8%). The elimination half‑life from the systemic circulation is approximately 5.8 hours.

⚠️ Metabolic caution: Concomitant use with strong CYP3A4 inhibitors (e.g., ritonavir, cobicistat) may increase systemic exposure; monitoring advised.

Clinical Efficacy in Allergic Rhinitis & Nasal Polyps

Nasonex is indicated for:

  • Seasonal and perennial allergic rhinitis in adults and children aged 3 years and older. Regular use reduces nasal congestion, rhinorrhoea, sneezing, and itching.
  • Nasal polyps in adults aged 18 years and over. It reduces polyp size and nasal obstruction, improving breathing.

In clinical trials, Nasonex demonstrated significant improvement in total nasal symptom scores within the first 2 days of treatment, with sustained effect over 12 months. Prophylactic use before pollen exposure prevents onset of hay fever symptoms.

Nasonex FAQs

Some people notice relief within 12 hours, but full benefit usually takes 2–4 days of regular use. Continue using daily for best results.

There is limited data. Use only if clearly needed and prescribed by your doctor. Uncontrolled allergic rhinitis can also affect pregnancy.

Headache, sneezing, nosebleeds, sore throat, and nasal ulcers. Nosebleeds are more common in nasal polyp patients using higher doses.

Yes, often combined with antihistamines or eye drops. However, tell your doctor about all medicines you take, especially other corticosteroids or HIV medications.

Remove the dust cap, gently pull off the nozzle, wash it and the cap in warm water, rinse, dry in a warm place, then reattach. Do not use a pin to unblock.

Need Nasonex with Expert Guidance?

If you suffer from hay fever or nasal polyps and think Nasonex may help, a UK‑registered doctor can assess your symptoms and provide a prescription online.

Secure Prescription & Next-Day Delivery

MHRA‑compliant | GPhC‑registered pharmacy | Discreet packaging | UK‑registered doctors

Start Allergy Consultation
Nabeel M. - Medical Content Manager at Chemist Doctor
Authored byNabeel M.

Medical Content Manager

Nabeel is a co-founder, and medical content manager of Chemist Doctor. He works closely with our medical team to ensure the information is accurate and up-to-date.

Medical Doctor

Dr. Feroz is a GMC-registered doctor and a medical reviewer at Chemist Doctor. He oversees acute condition and urgent care guidance.

Usman Mir - Superintendent Pharmacist
Approved byUsman Mir

Medical Director

Usman is a co-founder, and medical director of Chemist Doctor. He leads the organisation's strategic vision, bridging clinical and operational priorities.

Review Date: 12 March 2026

Next Review: 12 September 2026

Published on: 12 March 2026

Last Updated: 12 March 2026